91 |
Women who Select Naturopathic Health Care During the Menopausal Transition: A Study in Grounded TheoryTibbetts, Dorothy S. 04 November 1994 (has links)
A grounded theory method was used to investigate the experiences of women who use naturopathic medicine, a system of alternative therapy, for health care during the menopausal transition. Transcripts of 16 in-depth interviews with women who received naturopathic health care during the menopausal transition were analyzed with respect to three research questions: (a) Why do women seek naturopathic health care during the menopausal transition? (b) Do women who use naturopathic treatment for menopausal health care share similar experiences of menopause? and ( c) Are women satisfied with the naturopathic treatment they receive for menopausal health care? Conditions leading to informants' use of naturopathy were represented by two categories: Practicing natural self-care, and Rejecting the conventional medical system Experiences of menopause were represented by three categories: It's not a singular event, Paying attention to changes in and around me, and Information helps. Informants' satisfaction with naturopathy for menopause-related health care was represented by four categories: Naturopathy is consistent with engaging in natural self-care practices, Naturopathy is effective in treating troubling menopausal signs, Naturopathy addresses individual and interrelated aspects of menopause, and Naturopathy provides moral and informational support. Continued analysis of the data revealed a core category, Exchanging infonnation, that provided a foundation for the theoretical model representing the experience of women who use naturopathic health care at menopause. The grounded theory developed in this study may be useful to health professionals by increasing understanding of the naturopathic health care option for menopausal women. Suggestions for further study include quantitative evaluation of components of the theory developed in this study, continued qualitative and quantitative investigation of aspects of information exchange between patients and their conventional and alternative practitioners, application of grounded theory methodology to studies of women's use of hormone replacement therapy, and application of grounded theory methodology to studies of patients' selection of alternative medicine for health matters other than menopause.
|
92 |
The use of complementary and alternative medicine (CAM) as lived by individuals living with chronic illnessesKumar, Ashwin, University of Western Sydney, College of Health and Science, School of Nursing January 2007 (has links)
This naturalistic exploratory study focused on Australians living with chronic illnesses who chose to use complementary and alternative medicine (CAM). The purpose of this sociological study was to discover and illuminate the lived experience of using CAM by individuals living with chronic illnesses in an attempt to understand their reasons for choosing CAM for their health care needs within the social contexts of their lives. The research question guiding this qualitative study was: Based upon a reflection of lived experiences, why do individuals living with chronic illnesses choose to use CAM? The major finding of this study was that research participants turned to CAM to find practical solutions for coping with pain and the ongoing demands of living daily lives while suffering and living with chronic illnesses. Unlike existing research findings, participants in this study did not turn to CAM for ideological reasons, nor were they seeking a holistic approach to health and health care. As such, the findings of this study strongly suggest that individuals living with chronic illnesses initially choose to use CAM for pragmatic reasons rather than ideological dispositions. However, the findings also suggest that after their initial use of CAM, individuals appear to adopt, via enculturation processes, more holistic ideologies resulting in modifications to perceptions of self, illness and health. / Doctor of Philosophy (PhD)
|
93 |
Development of an evidence-based Chinese herbal medicine for the management of vascular dementiaLiu, Junguang, University of Western Sydney, College of Health and Science, Centre for Complementary Medicine January 2008 (has links)
Vascular dementia (VaD), the second most common cause of dementia, causes substantial distress to patients and represents a significant burden to their families and communities. Currently, there is no effective treatment to reverse the brain damage associated with VaD. In general the drugs available for the management of cognitive problems in VaD are expensive and outcomes are uncertain. It is, therefore, important to seek out alternative approaches, which may prove effective, cheaper and safer. Chinese herbal medicine (CHM) has been used for the treatment of dementia-like disorders for centuries. Data from many preclinical studies and some clinical studies have suggested the potential effectiveness of CHM for the treatment of VaD. Based on the literature review conducted as part of this thesis, however, most of the studies were published in Chinese literature and failed to demonstrate methodological rigour or to report sufficient methodological detail. Randomised controlled trials (RCTs) using scientific methods of diagnosis and outcome measures are urgently needed. Wei Nao Kang (WNK) is a three-herb formula developed by Xi Yuan Hospital, China Academy of Chinese Medical Sciences. Preclinical experiments of WNK have demonstrated significant improvement in learning and memory function in VaD animal models in rats and mice. Human case studies have also signalled the potential value of WNK in VaD. Although the results of these studies were encouraging, strong scientific evidence from a well-designed RCT is still required. A rigorous clinical trial methodology, including scientific diagnostic criteria and outcome measures, was designed and applied to the evaluation of WNK for VaD. The trial was successfully conducted over a two-year period. Cognitive functions, as evidenced by the ADAS-cog, were significantly improved in the study group taking WNK herbal medication compared with the placebo group. The ADAS-cog was simultaneously validated as a measure of cognitive function in VaD. Blinding was verified and no major adverse effects were found related to WNK treatment. However, neither group demonstrated long-lasting effect on a 16 weeks follow-up after completion of treatment. WNK demonstrated a significant effect on quality of life (measured by SF-36) and some effect on activities of daily living (measured by ADCS-ADL) in VaD patients. The SF-36 was validated as a measure of general health status and the ADCS-ADL as a measure of activities of daily living in patients with VaD. Both scales were proven sensitive to the presence of VaD, and provided useful supplementary outcome measures for VaD. A cerebral perfusion study was conducted to identify changes in cerebral blood flow and its relationship with clinical symptoms. The study showed that WNK had marked increases in blood flow in the inferior frontal and anterior temporal regions, both of which are closely related to cognitive function in human brains. This study has provided scientific evidence in support of the clinical effect of WNK on VaD. In addition, it validated several outcome measures in assessing improvements in cognitive functions, activities of daily living and quality of life in VaD patients. One of the highlights of this study is the application of SPECT scans as an outcome measure. This provided an excellent objective parameter for assessing the effects of WNK. To the best of our knowledge, SPECT scanning has never been used in VaD trials of herbal medicines. / Doctor of Philosophy (PhD)
|
94 |
Beneficial effects of lycium barbarum in rat depression modelZhang, Endong, 张恩东 January 2011 (has links)
published_or_final_version / Anatomy / Doctoral / Doctor of Philosophy
|
95 |
An exploration of women's current hormone discontinuation experiences, influences, decisions, and alternativesKupferer, Elizabeth Mary, 1958- 28 August 2008 (has links)
Findings released from recent pivotal clinical trials on hormone therapy (HT) benefits and risks have stimulated a growing trend towards lower doses and earlier discontinuation of HT for menopausal women. Yet, there is little knowledge regarding women's personal experiences with the resultant earlier and possibly abrupt withdrawal of HT. The purpose of this study was to explore postmenopausal women's vasomotor symptom experiences after discontinuing HT. The data for this study was collected from menopausal women who discontinued HT. The study questionnaire was created through an extensive review of the literature as well as an expert panel review. The questionnaire was also piloted with a small group of women prior to its use in this study. Data analysis consisted of descriptive analysis with means and standard deviations and/or frequency distributions with percentages for demographic data, health behaviors, factors influencing HT decisions, use of CAM and perceived efficacy. Chi-square analysis, Spearman Rho correlation, and logistic regression analysis were conducted for contextual factors and vasomotor symptom experiences. A McNemar test was performed to assess within group differences for vasomotor symptoms experiences pre and post HT. Questionnaires were received from 563 menopausal women throughout the United States. This study revealed that 80% of participants experienced vasomotor symptoms after discontinuing HT. The most common predictors which accounted for only 13% of variance in the occurrence of vasomotor symptoms were younger age, type of menopause and the occurrence of vasomotor symptoms prior to initiation of HT. Of the 563 women participating in the study, less than half reported the use of CAM to treat reemerging vasomotor symptoms. For the most part, less than half of the women felt their treatment choices were helpful in relieving their reemerging vasomotor symptoms Because a woman's experience of menopause can be highly individualized, an adaptation of Bronfenbrenner's ecological theory was used guide this exploratory study. The study findings supported the usefulness of the adaptation of Bronfenbrenner's ecological theory as a model through which to view the vasomotor experiences of menopausal women who have discontinued HT. / text
|
96 |
The role of traditional healers in the fight against HIV/AIDS : the case study of Tembisa Township, South Africa.Nkungwana, Siyasanga. January 2005 (has links)
South Africa has a high HIV/AIDS prevalence. Due to the unavailability of antiretroviral drugs and South African’s trust in traditional healers for health problems, traditional healers are involved in treating HIV/AIDS. This dissertation outlines traditional healers’ role in HIV/AIDS in Tembisa, a township situated in the East Rand section of Johannesburg. People living with HIV/AIDS, traditional healers and health care workers were interviewed. The dissertation also confirms the high prevalence of HIV/AIDS in Tembisa.. According to the dissertation, a reasonable highest number of People Living with HIV/AIDS (PLWAS) 8 out of 10 consulted Traditional healers to seek treatment of HIV/AIDS Opportunistic infections, although three out of eight indicated that consulting traditional healers was not necessarily their own choice. Two PLWAS do not believe in traditional healers and have never consulted them. Five PLWAS’s view was that Traditional healers can treat opportunistic infections effectively and they indicated their own health bear evidence to such claims. The study had shown that, although traditional healers have shown good rapport with their clients, and have earned positive respect due to their involvement in HIV/AIDS prevention and treatment in their communities, there are also challenges with regards to their work that calls for urgent attention. For an example, a highest number of Traditional healers did misrepresent diseases related to sexual intercourse, and also they could not recognize the symptoms of HIV/AIDS. They also hardly gave all biomedical perspective of transmission of HIV/AIDS without being probed. Both the group that believed in traditional healers and those that do not, as well as Biomedicine indicated that using traditional healers alone without biomedicine is not a realistic option.due to their training that is not homogenous and their profession that is rarely regulated. All the participants interviewed were in support of the strong collaboration between traditional healers and Biomedicine. / Thesis (M.A.)-University of KwaZulu-Natal, Durban, 2005.
|
97 |
Effects and mechanisms of interleukin-10 promoter polymorphisms on HIV-1 susceptibility and pathogenesis.Naicker, Dshanta Dyanedi. 11 November 2013 (has links)
HIV infection has risen to pandemic proportions. Interleukin-10 (IL-10), a potent antiinflammatory
cytokine has been shown to enhance the establishment and persistence of
chronic viral infections through inactivation of effector antiviral immune responses and it
may also directly influence HIV-1 replication in cells of diverse lineages. IL-10 promoter
polymorphisms have been shown to affect HIV-1 susceptibility and pathogenesis. However,
the underlying mechanisms are poorly understood. We investigated the relationship between
IL-10 promoter variants, plasma IL-10 levels, and markers of disease outcome in chronically
HIV-1-infected individuals. To investigate the mechanistic role of IL-10 and its genetic
variants on HIV pathogenesis, we studied markers of activation on B cells, CD4+ and CD8+ T
cells, and assessed effects on CD4+ T cell proliferation with and without blockade of the IL-
10 pathway.
We used Taqman genotyping assays to genotype three IL-10 promoter single nucleotide
polymorphisms (SNPs) in our study cohort. Baseline plasma IL-10 levels were measured
using Luminex technology for 112 individuals. Viral load, CD4+ T cell counts and cytotoxic
T lymphocyte (CTL) immune responses were measured at baseline. The rate of CD4+ T cell
decrease was calculated in 300 individuals with a median follow-up of 25 months. CD38,
CD95, Ki67, IgG and PD-1, markers of activation or exhaustion were measured on B cells,
and CD38, CD95, Ki67, HLA-DR and PD-1 were measured on CD4+ and CD8+ T cells in a
subset of 63 individuals. CD4+ T cell proliferation was measured using Carboxyfluorescein
succinimidyl ester (CFSE) assays, following IL-10 receptor blockade in a subset of 31
individuals.
The IL-10 -1082G, -592A and -3575 variants were observed at frequencies of 0.3, 0.34 and
0.23 respectively, in our study cohort. Plasma IL-10 levels were significantly higher in the -
1082GG group than in the combined AA/AG group (p=0.0006). There was a significant
association between the 592AA genotype and a greater breadth of CTL responses compared
to the CC and CA (p= 0.002 and 0.004 respectively). The -592AA genotype associated
significantly with an attenuated loss of CD4 cells (p= 0.0496), with -592AA having the least
change in CD4 cells per year. The median expression of HLA-DR, a marker of T cell
activation was significantly higher in the-1082AA group for CD8 cells (p= 0.047), and the -
592AA group for CD4 T cells (p= 0.01). The median expression of IgG on the surface of B
cells was significantly higher in the -1082GG genotype and the -592CC genotype (p=0.0183
and 0.0659 respectively). Overall, IL-10 variants correlated with IL-10 expression and CD4
decline during chronic HIV-1 infection. IL-10 promoter variants may influence the rate of
HIV-1 disease progression by regulating IL-10 levels, which in-turn, may affect the breadth
of CTL responses. Furthermore, the increased expression of HLA-DR and PD-1 on CD8+ and
CD4+ T cells, indicates that lower IL-10 levels are associated with increased immune
activation and immune exhaustion. The increased expression of IgG on B cells, suggests that
in a setting of lower IL-10, there is possibly a bias towards a Th2 immune response. These
data suggest a significant role for IL-10 genetic variants and IL-10 in HIV pathogenesis.
Further studies to determine whether and how the IL-10 pathway may be manipulated for
therapeutic or vaccine strategies for HIV are warranted. / Thesis (Ph.D.)-University of KwaZulu-Natal, Durban, 2012.
|
98 |
Studies on some pharmacological properties of Capsicum frutescens-driven capsaicin in experimental animal models.Jolayemi, Adebayo Taiwo Ezekiel. January 2012 (has links)
The present study investigated pharmacological properties of Capsicum frutescens-derived capsaicin, including its analgesic, anti-inflammatory and coagulatory properties. The effects of capsaicin on gastrointestinal and myocardial muscles, as well as on myocardial ischaemic-reperfusion, were also investigated.
Capsaicin pre-treatment in neonatal rats has been found to abolish the development of thermal hyperalgesia produced in a model of neuropathic pain in rats (Toth-Kasa et al., 1986). In addition, capsaicin sensitivity has been found to be dependent on continued presence of nerve growth factor (NGF), whose concentration increases in inflamed tissues (Bevan and Winter, 1995). By stimulating the release of excitatory amino acids (EAA); such as glutamate and neuropeptides [(CGRP, neurokinin A (NKA) and Substance P (SP)] from both the peripheral and central terminals of sensory neurones by two mechanisms (Kroll et al., 1990; Del Bianco et al., 1991; Lou et al., 1992; 1994; Woolf et al., 1994); capsaicin has been shown to produce a longer-term inhibitory effect. This is one likely mechanism for capsaicin analgesic and anti-inflammatory actions (Bleakman et al., 1990).
Within the gastro-intestinal tract, SP and NKA are involved in the physiological control of several digestive functions, such as motility, fluid and electrolyte secretion, blood flow, and tissue homeostasis (Otsuka, 1993; Holzer et al., 1997). Consistent with this finding, upsurge of SP in irritable bowel syndrome (IBD) was confirmed by Mantyh et al, (1988). Pre-treatment of rats with either capsaicin or NK-1R antagonists dramatically reduced fluid secretion, mucosal permeability, and intestinal inflammation in animal models of acute and chronic inflammation (McCafferty et al, 1994; Pothoulakis et al., 1994).
Capsaicin can modulate endocrine and paracrine activities, immune responses, as well as gastro-intestinal and cardiovascular functions. Moreover, up-regulation of Substance P receptors was found to be associated with chronic inflammatory conditions (De et al., 1990). Stimulation of transient receptor potential vanilloid 1 also results in the activation of nociceptive and neurogenic inflammatory responses (Rigoni et al., 2003).
vi
The pharmacodynamic effects of capsaicin on the cardiovascular system remain elusive. Some actions of capsaicin on the heart were attributed to an interaction at K+ channels (Castle, 1992), or liberation of neuropeptides, most notably calcitonin-gene-related-peptide (CGRP) from the vanilloid-sensitive innervation of the heart (Franco-Cereceda et al., 1988; 1991). The possibility of a direct effect of capsaicin on the heart via a cardiac vanilloid receptor (VR), or through interaction of vanilloid receptors with purinergic receptors, and subsequent release of nitric oxide (NO), leading to vasodilatation were considered. Evidence abound in the literature that Ca2+ ions are released through 1, 4, 5 inositol phosphatase by the release of phospholipase C, or through interaction of the vanilloid receptors with cannabinoids. In an earlier study, Jaiarj et al. (1998) found that capsaicin acting on the heat-sensitive vanilloid receptors, had thrombolytic effects. Though weak evidence, Jaiarj et al. (1998) observed that individuals who consume large amounts of Capsicum have lower incidence of thromboembolism.
Following ethical approval, the study reported in this thesis was conducted in phases. Identification of Capsicum frutescens (facilitated by a botanist in the Department of Botany, Westville campus of the University of KwaZulu Natal). Chromatographic extraction of capsaicin from Capsicum frutescens was followed by Nuclear Magnetic Resonance (NMR) analysis of the extract. Animal studies were conducted using capsaicin extract (CFE) and/or a reference capsaicin (CPF), using „hot plate. and „acetic acid. test methods to investigate the role of capsaicin on analgesia. Fresh egg albumin-induced inflammation was used to investigate the role of capsaicin in inflammation, following pre-treatment with CFE and CPF. Concentraton-response curves of increasing concentrations of capsaicin, acetylcholine and other agonist drugs with specific antagonists on strips of chick oesophagus, guinea-pig ileum, and rabbit duodenum were constructed following investigations on gastrointestinal (GIT) smooth muscles. The effect of capsaicin on coagulation was assessed by measuring international normalized ratio (INR) of animals that were exposed to different concentrations of capsaicin (CFE and CPF). Furthermore, parallel control studies were conducted in each of these investigations using distilled water or saline as placebo-control or specific-prototype agonists. negative-control. Cardiovascular investigations included studies on the effects of capsaicin on the heart rate, inotropy,
vii
coronary perfusion pressure, and ischaemic-reperfusion injury, using Langendorf.s rat heart models.
Collated data were triangulated by manual hand-written and PowerLab data acquisition, or computerised capture. Statistical analysis were performed by either one or two of the following: Student.s t-test, ANOVA (repeated or single–use modes), facilitated and confirmed by Graph Pad Prism, Microsoft Excel or CPSS software(s).
Reproducibility and relevance to the stated objectives of the various studies were confirmed by assessing which of the Null or Alternative hypothesis is validated by the results from the test.
Treatment with CFE or CPF at all doses significantly (p<0.01) increased MRT. By comparison with control, writhing responses to acetic acid were significantly reduced following pre-treatment with various doses of CFE or CPF. The results in both parallel groups of CFE and CPF in the hot plate and acetic acid tests had Pearson correlation of one (1).
Compared to the diclofenac (DIC) group, the degree of inhibition of paw oedema by CFE and CPF was statistically significant (P<0.05-0.001), best in the first 4 hours of treatment.
The results of the in vitro laboratory animal study indicate that relatively low concentration of CPF (20 or 40 .g) produced significant (p.0.05), concentration-related inhibitions of acetylcholine (0.1-5 .g)-induced contractions of the chick isolated oesophagus, guinea-pig isolated ileum and rabbit isolated duodenum. Biphasic effects, which were noticed at low concentrations, consisted of initial brief contractions, followed by longer-lasting relaxations and reductions of the contractile amplitudes of the muscle preparations. Percentage inhibitions of the smooth muscle contractions by CFE or CPF were concentration-dependent, ranging from 20-70% (p<0.02). / Thesis (Ph.D.)-University of KwaZulu-Natal, Westville, 2012.
|
99 |
The effects of Tulbaghia violacea leaf, bulb and stalk extracts on Jurkat cells.Mackenzie, Jared Stuart. January 2012 (has links)
Studies have shown that the traditional healers have used Tulbaghia violacea (TV) (also
known as ‘wild garlic’) for the treatment of a number of ailments including fever,
tuberculosis, stomach problems, and oesophageal cancer. However, little is known with
regards to the anticancer and antiproliferative properties of this plant. Therefore, this
study investigated the effects of TV and domesticated garlic extracts on Jurkat cells, in
order to determine whether or not these extracts possess anti-proliferative properties.
Cultured Jurkat cells were treated with IC50 concentrations of garlic (14μg/ml), TV leaf
(256μg/ml), TV bulb (225μg/ml) and TV stalk (216μg/ml) extracts as determined by the
methylthiazol tetrazolium assay. Free radical production was measured using the
thiobarbituric acid reactive substance (TBARS) and nitric oxide (NO) assays, while
glutathione (GSH) concentration was measured using the GSH-Glo™ assay. The
apoptosis inducing properties of each extract were measured using flow cytometry
(Annexin V- Fluos and JC-1 assays) and luminometry (caspases 3/7, 8, 9 and ATP).
Western blots were run to determine protein expression, while comet and DNA
fragmentation assays were used to determine the level of DNA damage induced. Wild
and domesticated garlic extracts induced a significant increase in malondialdehyde
concentration ([MDA]), with TV bulb extract inducing the highest concentration
(p<0.0001). A significant increase in NO concentration was observed in the bulb
(p<0.0001) and stalk (p<0.001) extracts, and leaf (p<0.05) and stalk (p<0.05) TV
extracts significantly increasing GSH concentration. The longest comet tails were
observed in TV bulb extracts (p<0.0001) and comprised mainly of single strand breaks,
while the comets induced following garlic exposure contained double strand breaks. All
extracts, except TV leaf, increased the percentage of cells undergoing apoptosis.
Tulbaghia violacea leaf induced a significant (p<0.0001) increase in percentage of cells
undergoing necrosis, whereas TV bulb resulted in a significant (p<0.0001) decrease.
All TV extracts induced caspase 3/7 and 9 activity, with the most significant increase in
caspase 9 activity observed for TV leaf and bulb. No significant change in caspase 3/7
activity was evident for domesticated garlic. Cleavage of PARP and expression of
NF B and HSP 70 occured for all extracts. However, HSP 70 was not differentially
expressed. Exposure to wild and domesticated garlic extracts induced peroxidative lipid
and DNA damage within the cells, indicating oxidative stress. This damage occurred in
conjunction with increased percentage of cells undergoing apoptosis and expression of
caspase 3/7. Therefore, these findings suggest that TV is inducing cell death through
apoptosis in Jurkat cells using a number of mechanisms, including the induction of
oxidative stress. This is of clinical significance, as cell death through apoptosis is the
preferred method of action for anti-cancer drugs. / Thesis (M.Med.)-University of KwaZulu-Natal, Durban, 2012.
|
100 |
People with multiple sclerosis in South East Queensland: A study of the use and cost of mainstream medicine and complementary therapiesCameron, Kaye D. Unknown Date (has links)
No description available.
|
Page generated in 0.0948 seconds